The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...
A bipartisan quartet of of senators on Wednesday unveiled legislation to cap the monthly cost of insulin at $35 for patients ...
The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
Scanning electron microscopy image of an insulin tree-like aggregate. Credit: Wikimedia Commons. For millions of people ...
“Insulin injections remain a daily burden for many patients,” said Associate Professor Shingo Ito. “Our peptide-based ...
Everyday Health on MSN
Once-a-week insulin shot could be a game changer for type 2 diabetes
Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...
Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.
FDA approves 1st weekly basal insulin, Awiqli, offering adults with Type 2 diabetes a once-weekly injection to improve ...
His research showed that Type 2 diabetes was caused by insulin resistance at the cellular level, a controversial idea that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results